Site Title Goes Here

Shortcut Navigation:


Take Action on Legislation

Tell Congress to protect you from toxic chemicals



Johnson & Johnson
J&J Commits to Safer Cosmetics Worldwide

Johnson & Johnson to phase out chemicals of concern from baby and adult cosmetics by 2015.



Janet Gray, Ph.D.
Janet Gray, Ph.D.

As author of our 2008 and 2010 State of the Evidence reports, Dr. Gray drives the science behind all our work.

Printer Friendly

References, Clear Science (Q-Z)

Scientific references for the Clear Science section of our website, previously published as the report, State of the Evidence: The Connection Between Breast Cancer and the Environment. Research and writing by Janet Gray, Ph.D. Parenthetical references from the science pages of our website are listed here in alphabetical order.

A   B   C   D   E   F   G   H   I   J   K   L   M

N   O   P   Q   R   S   T   U   V   W   X   Y   Z


Quach, T., Nguyen, K., Doan-Billings, P., Okahara, L., Fan, C., & Reynolds, P. (2008). A preliminary study of Vietnamese nail salon workers in Alameda County, California. J Commun Health, 33, 336–343.

Quinn, M. M., Sembajwe, G., Stoddard, A. M., Kriebel, D., Krieger, N., Sorensen, G., … Barbeau, E. M. (2007). Social disparities in the burden of occupational exposures: results of a cross-sectional study. Am J Ind Med, 50(12), 861–875. 


Rabstein, S., Brüning, T., Harth, V., Fischer, H.-P., Haas, S., Weiss, T., … Pesch, B. (2010). N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer. Eur J Cancer Prev, 19(2), 100–109.

Rajapakse, N., Silva, E., & Kortenkamp, A. (2002). Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Persp, 110, 917–921.

Rajapaske, N., Ong, D., & Kortenkamp, A. (2001). Defining the impact of weakly estrogenic chemicals on the action of steroidal chemicals. Toxicol Sci, 60, 296–304.

Ralston, S., Coffing, S., Seidel, A., Luch, A., Platt, K., & Baird, W. (1997). Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem Res Toxciol, 10, 687–693.

Ramamoorthy, K., Wang, F., Chen, I., Safe, S., Norris, J., McDonnell, D., … Korach, K. (1998). Potency of combined estrogenic pesticides: Synergism between synthetic estrogens. Science, 275, 405–406.

Rappaport, S. M. (2011). Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol, 21(1), 5–9.

Rastogi, S., Schouten, A., De Kruijf, N., & Weijland, J. (1995). Contents of methylparaben, ethylparaben, propylparaben, butylparaben and benzylparaben in cosmetic products. Contact Derm, 32, 28–30.

Rauh, V. A., Landrigan, P. J., & Claudio, L. (2008). Housing and health: intersection of poverty and environmental exposures. Ann NY Acad Sci, 1136, 276–288. 

Ravdin, P., Cronin, K., Howlader, N., Berg, C., Chlebowski, R., Feuer, E., … Berry, D. (2007). Decrease in breast cancer incidence in 2003 in the United States. New England J Med, 356, 1670–1674.

Raynor, J., Enoch, R., & Fenton, S. (2005). Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci, 87, 255–266.

RC, S., & CJ, P. (1999). Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3- butadiene) in F344/N rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis, 20, 867–878.

Redberg, R. (2009). Cancer risks and radiation exposure from computed tomographic scans. How can we be sure that the benefits outweigh the risks. Arch Intern Med, 169, 2049–2050.

Rees Clayton, E. M., Todd, M., Dowd, J. B., & Aiello, A. E. (2011). The impact of bisphenol A and triclosan on immune parameters in the U.S. population, NHANES 2003-2006. Environ Health Persp, 119(3), 390–396.

Reeves, G., Beral, V., Green, J., Gathani, T., & Bull, D. (2006). Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol, 7, 910–918.

Rennix, C., Quinn, M., Amoroso, P., Eisen, E., & Wegman, D. (2005). Risk of breast cancer among enlisted army women occupationally exposed to volatile organic compounds. Am J Ind Med, 48, 157–167.

Rennstam, K., & Hedenfalk, I. (2006). Molecular signatures of progression from benign epithelium to metastatic breast cancer Breast. Cancer Res, 8, 213.

Reynolds, J. (1997). International pesticide trade: Is there any hope for the effective regulation ofcontrolled substances. J Land Use & Environ Law.

Reynolds, P., Hurley, S., Goldberg, D., Anton-Culver, H., Bernstein, L., Deapen, D., … Ziogas, A. (2004). Active smoking, household passive smoking, and breast cancer: Evidence from the California Teachers Study. J Natl Cancer Inst, 96, 29–37.

Rice, S., & Whitehead, S. (2006). Phytoestrogens and breast cancer: promoters or protectors. Endocr Relat Cancer, 13, 995–1015.

Richter, C., Birnbaum, L., Farabollini, F., Newbold, R., Rubin, B., Talsness, C., … Vom Saal, F. (2007). In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol, 24, 199–224.

Rivas, A., Lacroix, M., Olea-Serrano, F., Laios, I., Leclercq, G., & Olea, N. (2002). Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol, 82, 45–53.

Robbins, A., & Clarke, C. (2007). Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol, 25, 3437–3439.

Roberts, D. (2011). Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-First Century. New York: The New Press.

Robinson, P., Mack, G., Remmers, J., Levy, R., & Mohadjer, L. (1990). Trends of PCB, hexachlorobenzene, and benzene hexachloride levels in the adipose tissue of the U.S. population. Environ Res, 53, 175–192.

Robison, A. K., Sirbasku, D. A., & Stancel, G. M. (1985). DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett, 27(1-3), 109–113.

Rodriguez-Mozaz, S., De Alda, M., & Barcelo, D. (2005). Analysis of bisphenol A in natural waters by means of an optical immmunosensor. Water Res, 39, 5071–5079.

Rogan, W. (1996). Pollutants in breast milk. Arch Pediatr Adolesc Med, 150, 81–90.

Rohr, J., & McCoy, K. (2009). A qualitative meta-analysis reveals consistent effects of atrazine on freshwater fish and amphibians. Environ Health Persp, 118, 20–32.

Ron, E., Ikeda, T., Preston, D., & Tokuoka, S. (2005). Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst, 97, 603–605.

Ronckers, C. M., Doody, M. M., Lonstein, J. E., Stovall, M., & Land, C. E. (2008). Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol, Biomar Prev, 17(3), 605–613. 

Roseboom, T., De Rooij, S., & Painter, R. (2006). The Dutch famine and its long-term consequences for adult health. Early Human Devel, 82, 485–491.

Rosenberg, L., Boggs, D. A., Wise, L. A., Adams-Campbell, L. L., & Palmer, J. R. (2010). Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev, 19(8), 2073–2079.

Rosenberg, Lynn, Zhang, Y., Coogan, P. F., Strom, B. L., & Palmer, J. R. (2009). A case-control study of oral contraceptive use and incident breast cancer. American journal of epidemiology, 169(4), 473–479. 

Rosenthal, M. S. (2008). Ethical problems with bioidentical hormone therapy. International journal of impotence research, 20(1), 45–52. 

Ross, R., Paganini-Hill, A., Wan, P., & Pike, M. (2000). Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Ins, 92, 328–332.

Rossouw, J., Anderson, G., Prentice, R., LaCroix, A., Kooperberg, C., Stefanick, M., … Ockene, J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc, 288, 321–333.

Routledge, E., Parker, J., Odum, J., Ashby, J., & Sumpter, J. (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol, 153, 12–19.

Roychoudhuri, R., Evans, H., Robinson, D., & Moller, H. (2004). Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer, 91, 868–872.

Rudel, R. A., Fenton, S. E., Ackerman, J. M., Euling, S. Y., & Makris, S. L. (2011). Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Persp, 119(8), 1053–1061. 

Rudel, R. A., Gray, J. M., Engel, C. L., Rawsthorne, T. W., Dodson, R. E., Ackerman, J. M., … Brody, J. G. (2011). Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Persp, 119(7), 914–920. 

Rudel, R. A., Seryak, L. M., & Brody, J. G. (2008). PCB-containing wood floor finish is a likely source of elevated PCBs in residents’ blood, household air and dust: a case study of exposure. Environ Health, 7,  art. no.2. 

Rudel, R., Attfield, K., Schifano, J., & Brody, J. (2007). Chemicals causing mammary gland tumors in animals signal new directions for epidemiological chemicals testing, and risk assessment for breast cancer prevention. Cancer, 109 (Suppl, 12, 2635–2666.

Rudel, R., Brody, J., Spengler, J., Vallarino, J., Geno, P., Sun, G., & Yau, A. (2001). Methods to detect selected potential mammary carcinogens and endocrine disruptors in commercial and residential air and dust samples. J Air Water Manag Assoc, 51, 499–513.

Rudel, R., Camann, D., Spengler, J., Korn, L., & Brody, J. (2003). Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endorcrine-disrupting compounds in indoor air and dust. Environ Sci Technol, 37, 4543–4553.

Rudel, R., Geno, P., Melly, S., Sun, G., & Brody, J. (1998). Identification of alkylphenols and other estrogenic phenolic compounds in wastewater, septage, and groundwater on Cape Cod, Massachusetts. Environ Sci Technol, 32, 861–69.

Rudel, R., & Perovich, L. (2009). Endocrine disrupting chemicals in indoor and outdoor air. Atmospheric Environ, 43, 170–181.

Rundle, A., Tang, D., Hibshoosh, H., Estabrook, A., Schnabel, F., Cao, C., … Perera, F. P. (2000). The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis, 21(7), 1281–1289.

Russo, J., Hu, Y., Silva, I., & Russo, I. (2001). Cancer risk related to mammary gland structure and development. Microsc Res Tech, 52, 204–223.

Russo, J., Moral, R., Wang, R., Russo, I., Lamartiniere, C., & Pereira, J. (2008). Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol, 196, 101–112.

Russo, Jose, Santucci-Pereira, J., De Cicco, R. L., Sheriff, F., Russo, P. A., Peri, S., … Russo, I. H. (2012). Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. International journal of cancer. J Int Cancer, 131(5), 1059–1070. 

Ryan, B., Hotchkiss, A., Crofton, K., & Gray Jr., L. (2010). In utero and lactational exposure to bisphenol A, in contrast to ethinyl estradiol, does not alter sectually dimorphic behavior, puberty, fertility, and anatomy of female LE rats. Toxicol Sci, 114, 133–148.


Sadler, A., Pugazhendhi, D., & Darbre, P. (2009). Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol, 114, 21–32.

Saeed, M., Rogan, E., & Cavalieri, E. (2009). Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: The defining link to natural estrogens. Int J Cancer, 124, 1276–1284.

Sagiv, S., Gaudet, M., Eng, S., Abrahamson, P., Shantakumar, S., Teitelbaum, S., … Gammon, M. (2009). Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environ Res, 109, 287–291.

Sakamoto, T., Horiguchi, H., Oguma, E., & Kayama, F. (2009). Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem, 21, 856–864.

Saleh, F., Behbehani, A., Asfar, S., Khan, I., & Ibrahim, G. (2011). Abnormal blood levels of trace elements and metals, DNA damage, and breast cancer in the state of Kuwait. Biol Trace Elem Rese, 141(1-3), 96–109.

Salehi, F., Turner, M., Phillips, K., Wigle, D., Krewski, D., & Aronson, K. (2008). Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health, 11, 276–300.

Salian, S., Doshi, T., & Vanage, G. (2009). Perinatal exposure of rats to Bisphenol A affects the fertility of male offspring. Life Sci, 85(21-22), 742–752. 

Sandau, C., Dewailly, E., Ayotte, P., Duffe, J., & Norstrom, R. (2000). Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian Inuit. Environ Health Persp, 108, 611–616.

Sanderson, J., Letcher, R., Heneweer, M., Giesy, J., & Van den Berg, M. (2001). Effects of chloro-S-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. Environ Health Persp, 109, 1027–1031.

Santodonato, J. (1997). Review of the estrogenic and antiestrogenic activity of poycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere, 34, 835–848.

Sathyanarayana, S., Karr, C., Lozano, P., Brown, E., Calafat, A., Liu, F., & Swan, S. (2008). Baby care products: Possible sources of infant phthalate exposure. Pediatrics, 121, 260–268.

Sathyanarayana, S., Swan, S., & Meeker, J. (2009). Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans Royal Soc, 364, 2097–2113.

Sawada, N., Iwasaki, M., Inoue, M., Takachi, R., Sasazuki, S., Yamaji, T., … Tsugane, S. (2012). Long-term dietary cadmium intake and cancer incidence. Epidemiology, 23(3), 368–376.

Saxena, S., Copas, A., Mercer, C., Johnson, A., Fenton, K., Erens, B., … Wellings, K. (2006). Ethnic variations in sexual activity and contraceptive use: national cross-sectional study. Contraception, 74, 224–233.

Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., & Hoover, R. (2000). Menopausal estrogen and estrogenprogestin replacement therapy and breast cancer risk. J Am Med Assoc, 283, 485–491.

Schecter, A., Birnbaum, L., Ryan, J., & Constable, J. (2006). Dioxins: An overview. Environ Res, 101, 419–428.

Schellong, G. (1998). Pediatric Hodgkin’s disease: Treatment in the late. Annals Oncol, 9, 115–119.

Schettler, T. (2005). Human exposure to phthalates via consumer products. Int J Androl, 29, 134–139.

Schlumpf, M., Cotton, B., Conscience, M., Haller, V., Steinmann, B., & Lichtensteiger, W. (2001). In vitro and in vivo estrogenicity of UV screens. Environ Health Persp, 109, 239–244.

Schonfelder, G., Wittfoht, W., Hopp, H., Talsness, C., Paul, M., & Chahoud, I. (2002). Parent Bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Persp, 110, 703–707.

Schootman, M., Jeffe, D. B., Lian, M., Gillanders, W. E., & Aft, R. (2009a). The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: A geographic and multilevel analysis. Am J Epidemiol, 169(5), 554–561.

Schootman, M., Jeffe, D., Lian, M., Gillanders, W., & Aft, R. (2009b). The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: A geographic and multilevel analysis. Am J Epidemiol, 169, 554–561.

Schuetz, F., Diel, I., Pueschel, M., Von Holst, T., Solomayer, E., Lange, S., … Sohn, C. (2007). Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Am J Obstet Gynecol, 196, 1–9.

Scribner, J., & Mottet, N. (1981). DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis, 2, 1235–1239.

Segaloff, A., & Maxfield, W. (1971). The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res, 31, 166–168.

Seifert, A., Helge, T., & Homback-Klonisch, S. (2009). TCDD mediates inhibition of p53 and activation of Era signaling in MCF-7 cells at moderate hypoxic conditions. Int J Oncol, 35, 417–424.

Setiawan, V. W., Haiman, C. A., Stanczyk, F. Z., Le Marchand, L., & Henderson, B. E. (2006). Racial/ethnic differences in postmenopausal endogenous hormones: The Multiethnic Cohort Study. Cancer Epidemiol Biomar Prev, 15(10), 1849–1855.

Shaham, J., Gurvich, R., Gorel, A., & Czerniak, A. (2006). The risk of breast cancer in relation to health habits and occupational exposures. Am J Ind Med, 49, 1021–1030.

Shakeel, M. K., George, P. S., Jose, J., Jose, J., & Mathew, A. (2010). Pesticides and breast cancer risk: a comparison between developed and developing countries. Asian Pac J Cancer Prev, 11(1), 173–180.

Shantakumar, S., Terry, M., Paykin, A., Teitelbaum, S., Britton, J., Moorman, P., … Gammon, M. (2007). Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol, 165, 1187–1198.

Shantakumar, S., Terry, M., Teitelbaum, S., Britton, J., Millikan, R., Moorman, P., … Gammon, M. (2007). Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat, 102, 365–374.

Sheffield, L., & Welsch, C. (1985). Zeranol (B-resorcylic acid lactone), a common residous component of natural foodstuffs, stimulates developmental growth of the mouse mammary gland. Cancer Lett, 28, 77–83.

Shen, H., Main, K., Virtanen, H., Damggard, I., Haavisto, A., Kaleva, M., … Schramm, K. (2007). From mother to child: Investigation of prenatal and postnatal exposure to persistent bioaccumulating toxicants using breast milk and placenta biomonitoring. Chemosphere, 67, 236–262.

Shen, L., Worrell, E., & Patel, M. (2009). Present and future development in plastics from biomass. Biofuel Bioprod Bior, 4, 25–40.

Shore, R., Hildreth, N., Woodard, E., Dvoretsky, P., Hempelmann, L., & Pasternack, B. (1986). Breast neoplasms in women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst, 77, 689–696.

Shoushtari, A., Michalowska, A., & Green, J. (2007). Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Disease, 28, 39–51.

Shu, X., Zheng, Y., Cai, H., Gu, K., Chen, Z., Zheng, W., & Lu, W. (2009). Soy food intake and breast cancer survival. J Am Med Assoc, 302, 2437–2443.

Sibbald, B., & Roland, M. (1998). Understanding controlled trials: why are randomised controlled trials important. Br Med J, 316, 201–1.

Siddiqui, M., Anand, M., Mehrotra, P., Sarangi, R., & Mathur, N. (2005). Biomonitoring of organochlorines in women with benign and malignant breast disease. Environ Res, 98, 250–257.

Sigurdson, A., MM, D., & RS, R. (2003). Cancer incidence in the U.S. Radiologic Technologists Health Study, 1983-1998. Cancer, 97, 3080–3089.

Sigurdson, AJ., Bhatti, P., Chang, S., Rajaraman, P., Doody, M., Bowen, L., … Struewing, J. (2009). Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. radiologic technologists. Breast Cancer Res Treat, 118, 177–184.

Silva, E., Scholze, M., & Kortenkamp, A. (2007). Activity of xenoestrogens at nanomolar concentrations in the E-screen assay. Environ Health Persp, 115 (Suppl, 1, 91–97.

Silva, N., Peiris-John, R., Wickremasinghe, R., Senanayake, H., & Sathiakumar, N. (2012). Cadmium a metalloestrogen: are we convinced? J Appl Toxicol 32(5), 318–332. 

Silver, S. R., Whelan, E. A., Deddens, J. A., Steenland, N. K., Hopf, N. B., Waters, M. A., … Ward, E. M. (2009). Occupational exposure to polychlorinated biphenyls and risk of breast cancer. Environ Health Persp, 117(2), 276–282. 

Silver, S., Whelan, E., Deddens, J., Steenland, N., Hopf, N., Waters, M., … Ward, E. (2009). Occupational exposure to polychlorinated biphenyls and risk of breast cancer. Environ Health Persp, 117, 276–282.

Simcox, N., Fenske, R., Wolz, S., Lee, I., & Kalman, D. (1995). Pesticides in household dust and soil: Exposure pathways for children of agricultural families. Environ Health Persp, 103, 1126–1134.

Simon, S., Weinstock, R., Doody, M., Neton, J., Wenzl, T., Stewart, P., … Linet, M. (2006). Estimating historical radiation doses to a cohort of U.S. radiologic technologists. Radiat Res, 166, 174–192.

Simpkins, J. W., Swenberg, J. A., Weiss, N., Brusick, D., Eldridge, J. C., Stevens, J. T., … Breckenridge, C. B. (2011). Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence. Toxicol Sci, 123(2), 441–459. 

Sims, A. (2009). Bioinformatics and breast cancer: What can high-throughput genomic approaches actually tell us. J Clin Pathol, 62, 879–885.

Siriwardhana, N., Choudhary, S., & Wang, H. (2008). Precancerous model of human breast epithelial cells induced by NNK for prevention. Breast Cancer Res Treat, 109, 427–441.

Skinner, M., Manikkam, M., & Guerrero-Bosagna, C. (2010). Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab, 21, 214–222.

SL, C., & Seidel, A. (1997). Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem Res Toxciol, 10, 687–693.

Slack, R., Gronow, J., & Voulvoulis, N. (2005). Household hazardous waste in municipal landfills: Contaminants in leachate. Sci Total Environ, 337, 119–137.

Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H., & Thun, M. (2006). Trends in breast cancer by race and ethnicity - Update 2006. Cancer, 56, 168–183.

Smith-Bindman, R., Lipson, J., Marcus, R., Kim, K., Mahesh, M., Gould, R., … Miglioretti, D. (2009). Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med, 169, 2078–2086.

Soler, D., Pampalona, J., Tusell, L., & Genesca, A. (2009). Radiation sensitivity increases with proliferation-associated telomere dysfunction in nontransformed human epithelial cells. Aging Cell, 8, 414–425.

Sondergaard, T. E., Hansen, F. T., Purup, S., Nielsen, A. K., Bonefeld-Jørgensen, E. C., Giese, H., & Sørensen, J. L. (2011). Fusarin C acts like an estrogenic agonist and stimulates breast cancer cells in vitro. Toxicology letters, 205(2), 116–121. 

Soni, M. G., Carabin, I. G., & Burdock, G. A. (2005). Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol, 43(7), 985–1015.

Sonnenschein, C., & Soto, A. (2000). The somatic mutation theory of carcinogenesis: Why it should be dropped and replaced. Mol Carcinogenesis, 29, 1–7.

Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J., Nobel, A., … Botstein, D. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Nat Acad Sci, 100, 8418–8423.

Soto, A., Chung, K., & Sonnenschein, C. (1994). The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Persp, 102, 380–383.

Soto, A., Justicia, H., Wray, J., & Sonnenschein, C. (1991). p-Nonyl-phenol: An estrogenic xenobiotic released from “modified” polystyrene. Environ Health Persp, 92, 167–173.

Soto, A., Maffini, M., Schaeberle, C., & Sonnenschein, C. (2006). Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract Res Clin Endocrinol Metab, 20, 15–33.

Soto, A., Maffini, M., & Sonnenschein, C. (2008). Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl, 31, 288–293.

Soto, A., & Sonnenschein, C. (2004). The somatic mutation theory of cancer: Growing problems with the paradigm. BioEssays, 26, 1097–1107.

Soto, A., Sonnenschein, C., Chung, K., Fernandez, M., Olea, N., & Serrano, F. (1995). The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Persp, 103 (Suppl, 7, 113–122.

Soto, A., Vandenberg, L., Maffini, M., & Sonnenschein, C. (2008). Does breast cancer start in the womb. Basic Clin Pharmacol Toxicol, 102, 125–133.

Sprague, B. L., & Trentham-Dietz, A. (2009). Prevalence of breast carcinoma in situ in the United States. J Am Med Assoc, 302(8), 846–848.

Sreeja, S., Santhosh Kumar, T.R., Lakshmi, B.S., & Sreeja, S. (2012). Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation. J Nutr Biochem23, 725–732.

Stahlhut, R., Welshons, W., & Swan, S. (2009). Bisphenol A data in NHANES suggest longer than expected half-life, substantial non-food exposure, or both. Environ Health Persp, 117, 784–789.

Stanford, J., Herrinton, L., Schwartz, S., & Weiss, N. (1995). Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology, 6, 181–183.

Steck, S., Gaudet, M., Eng, S., Britton, J., Teitelbaum, S., Neugut, A., … Gammon, M. (2007). Cooked meat and risk of breast cancer: Lifetime versus recent dietary intake. Epidemiology, 18, 373–382.

Steenland, K., Whelan, E., Deddens, J., Steyner, L., & Ward, E. (2003). Ethylene oxide and breast cancer incidence in a cohort study of 7,576 women. Cancer Causes Control, 14, 531–539.

Steingraber, S. (2007). The Falling Age of Puberty in U.S. Girls: What We Know, What we Need to Know. San Francisco: Breast Cancer Fund.

Stevens, R. (2009). Working against our endogenous circadian clock: Breast cancer and electric lighting in the modern world. Mutat Res, 680, 106–108.

Stevens, R. G., Hansen, J., Costa, G., Haus, E., Kauppinen, T., Aronson, K. J., … Straif, K. (2011). Considerations of circadian impact for defining “shift work” in cancer studies: IARC Working Group Report. Occup Environ Med, 68(2), 154–162.

Stewart, L. M., Holman, C. D. J., Hart, R., Bulsara, M. K., Preen, D. B., & Finn, J. C. (2012). In vitro fertilization and breast cancer: is there cause for concern? Fertil Steril, 98(2), 334–340. 

Stoker, T. E., Gibson, E. K., & Zorrilla, L. M. (2010). Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol Sci, 117(1), 45–53.

Stovall, M., Smith, S. A., Langholz, B. M., Boice, J. D., Jr, Shore, R. E., Andersson, M., … Bernstein, J. L. (2008). Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Rad Oncol, 72(4), 1021–1030. 

Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., … Cogliano, V. (2007). Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol, 8(12), 1065–1066.

Stuebe, A., Willett, W., Xue, F., & Michels, K. (2009). Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med, 169, 1364–1371.

Sudharshan, S., Naidu, R., Mallavarapu, M., & Bolan, N. (2012). DDT remediation in contaminated soils: a review of recent studies.

Sugiura-Ogasawara, M., Ozaki, Y., Sonta, S., Makino, T., & Suzumori, K. (2005). Exposure to bisphenol A is associated with recurrent miscarriage. Human Reprod, 20, 2325–2429.

Sukocheva, O., Yang, Y., Gierthy, J., & Seegal, R. (2005). Methyl mercury influences growth-related signaling in MCF-7 breast cancer cells. Environ Toxicol, 20, 32–44.

Suman, S., Johnson, M. D., Fornace Jr., A. J., & Datta, K. (2012). Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland. International J Radiat Oncol, 84(2), 500–507.

Swan, S., Main, K., Liu, F., Stewart, S., Kruse, R., Calafat, A., … Teague, J. (2005). Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Persp, 113, 1056–1061.

Swartz, C., Reddy, S., Benotti, M., Yin, H., Barber, L., Brownawell, B., & Rudel, R. (2006). Steroid estrogens, nonylphenol ethoxylate metabolites, and other wastewater contaminants in groundwater affected by a residential septic system. on Cape Cod, MA. Environ Sci Technol, 40, 4894–4902.

Swedenborg, E., & Pongratz, I. (2010). AhR and ARNT modulate ER signaling. Toxicology, 268(3), 132–138.

Sweeney, C., Giuliano, A., Baumgartner, K., Byers, T., Herrick, J., Edwards, S., & Slattery, M. (n.d.). Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer, 121, 2517–2523.


Talsness, C. (2008). Overview of toxicological aspects of polybrominated diphenyl ethers: A flame-retardant additive in several consumer products. Environ Res, 108, 158–167.

Tamimi, R.M., Colditz, G.A., Hazra, A., Baer, H.J., Hankinson, S.E., Rosner, B., Marotti, J., Connolly, J.L., Schnitt, S.J., and Collins, L.C. (2012). Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res. Treat. 131, 159–167.

Taylor, J. A., Vom Saal, F. S., Welshons, W. V., Drury, B., Rottinghaus, G., Hunt, P. A., … Vande Voort, C. A. (2011). Similarity of bisphenol a pharmacokinetics in rhesus monkeys and Mice: Relevance for human exposure. Environ Health Persp, 119(2), 422–430.

Teeguarden, J. G., Calafat, A. M., Ye, X., Doerge, D. R., Churchwell, M. I., Gunawan, R., & Graham, M. K. (2011). Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci: An Official Journal of the Society of Toxicology, 123(1), 48–57. 

Teitelbaum, S., Britton, J., Gammon, M., Schoenberg, J., Brogan, D., Coates, R., … Brinton, L. (2003). Occupation and breast cancer in women 20-44 years of age (United States).  Cancer Causes Control, 14, 627–637.

Tharp, A. P., Maffini, M. V., Hunt, P. A., VandeVoort, C. A., Sonnenschein, C., & Soto, A. M. (2012). Bisphenol A alters the development of the rhesus monkey mammary gland. Proc Nat Acad Sci 109(21), 8190–8195.

Thomas, P., & Dong, J. (2006). Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: A potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol, 102, 175–179.

Thompson, D., Kriebel, D., Quinn, M., Wegman, D., & Eisen, E. (2005). Occupational exposure to metalworking fluids and risk of breast cancer among female autoworkers. Am J Indust Med, 47, 153–160.

Thompson, P., DeMarini, D., Kadlubar, F., McClure, G., Brooks, L., Green, B., … Ambrosone, C. (2002). Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagenesis, 39, 134–142.

Tice, R.R., Austin, C.P., Kavlock, R.J., & Bucher, J.R. (2013). Improving the human hazard characterization of chemicals: A Tox21 update. Envir Health Persp 121, 756–765.

Tilghman, S. L., Bratton, M. R., Segar, H. C., Martin, E. C., Rhodes, L. V., Li, M., … Burow, M. E. (2012). Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS ONE, 7(3).

Titus-Ernstoff, L., Hatch, E., Hoover, R., Palmer, J., Greenberg, E., Ricker, W., … Hartge, P. (2001). Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer, 84, 126–133.

Tiwary, C. (1998). Premature sexual development in children following the use of estrogen- or placenta- containing hair products. Clin Pediatr, 37, 733–739.

Tiwary, C., & Ward, J. (2003). Use of hair products containing hormone or placenta by U.S. military personnel. J Pediatr Endocrinol Metab, 16, 1025–1032.

Toft, G., Jönsson, B. A. G., Lindh, C. H., Jensen, T. K., Hjollund, N. H., Vested, A., & Bonde, J. P. (2012). Association between pregnancy loss and urinary phthalate levels around the time of conception. Environ Health Persp, 120(3), 458–463. 

Tokunaga, M., Land, C., Tokuoka, S., Nishimori, I., Soda, M., & Akiba, S. (1994). Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res, 138, 1950–1985.

Toppari, J., & Juul, A. (2010). Trends in pubertal timing in humans and environmental modifiers. Mol Cell Endocrinol, 324, 39–44.

Touillaud, M., Thiebaut, A., Fournier, A., Niravong, M., Boutron-Ruault, M., & Clavel-Chapelon, F. (2007). Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst, 99, 475–86.

Travis, R., Allen, N., Appleby, P., Spencer, E., Roddam, A., & Key, T. (2008). A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer, 122, 705–710.

Troisi, R., Hatch, E., Titus-Ernstoff, L., Hyer, M., Palmer, J., Robboy, S., … Hoover, R. (2007). Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer, 121, 356–360.

Troisi, R., Potischman, N., Roberts, J., Siiteri, P., Daftary, A., Sims, C., & Hoover, R. (2003). Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States).. Cancer Causes Control, 14, 347–355.

Trowbridge, J., Sutton, P., Stotland, N., Charlesworth, A., Atchley, D.,& Woodruff, T. Clinicians and their role in reproductive environmental health. From

Tsai, K., Chuang, E., Little, J., & Yuan, Z. (2005). Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Res, 65, 6734–6744.

Tsigonia, A., Lagoudi, A., Chandriou, S., Linos, A., Evlogias, N., & Alexopoulos, E. (2010). Indoor air in beauty salons and occupational health exposure of cosmetologists to chemical substances. Int J Environ Res Public Health, 7, 314–324.

Turesky, R. (2007). Formation and biochemistry of carcinogenic heterocyclic aromatic amines in cooked meats. Toxicol Lett, 168, 219–227.

Turkoz, F.P., Solak, M., Petekkaya, I., Keskin, O., Kertmen, N., Sarici, F., Arik Z., Babaacan T., Ozisik, Y., Altundag, K. (2013).  Association between common risk factors and molecular subtypes in breast cancer patients. The Breast 22: 344-350.

Turnbull, C., Mirugaesu, N., & Eeles, R. (2006). Radiotherapy and genetic predisposition to breast cancer. Clin Oncol, 18, 257–267.

Tward, J., Wendland, M., Shrieve, D., Szabo, A., & Gaffney, D. (2006). The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer, 107, 108–115.

Tynes, T., Andersen, A., & Langmark, F. (1992). Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. Am J Epidemiol, 136, 81–88.

Tyrrell, J., Melzer, D., Henley, W., Galloway, T.S., & Osborne, N.J. (2013). Associations between socioeconomic status and environmental toxicant concentrations in adults in the USA: NHANES 2001-2010. Environ Int 59, 328–335.


Ueda, M., Imai, T., Takizawa, T., Onodera, H., Mitsumori, K., Matsui, T., & Hirose, M. (2005). Possible enhancing effects of atrazine on growth of 7, 12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-dawley rats. Cancer Sci, 96, 19–25.

Updike, M., Sawdy, J., Wang, L., Liu, S., Huang, Y., Ye, W., … Wick, M. (2007). Primary cultured human breast epithelial cells up-regulate protein disulfide isomerase in response to zeranol. Anticancer Res, 27, 407–410.

Uppala, P. T., Roy, S. K., Tousson, A., Barnes, S., Uppala, G. R., & Eastmond, D. A. (2005). Induction of cell proliferation, micronuclei and hyperdiploidy/polyploidy in the mammary cells of DDT- and DMBA-treated pubertal rats. Environ Molecr Mutag46(1), 43–52.

Urban, M., Banks, E., Egger, S., Canfell, K., O’Connell, D., Beral, V., & Sitas, F. (2012). Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med, 9(3), e1001182. 

USPSTF. (2009). Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 151, 716–727.


Valeron, P., Pestano, J., Luzardo, O., Zumbado, M., Almeida, M., & Boada, L. (2009). Differential effects exerted on human mammary epithelial cells by environmentally relevant organochlorine pesticides either individually or in combination. Chem-Biolog Interact, 180, 485–491.

Van Duursen, M. B. M., Nijmeijer, S. M., De Morree, E. S., De Jong, P. C., & Van den Berg, M. (2011). Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology, 289(2-3), 67–73.

Van Meeuwen, J., Ter Burg, W., Piersma, A., Van den Berg, M., & Sanderson, J. (2007). Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells. Food Chem Toxicol, 45, 2319–2330.

Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R. Jr, Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T. and Myers J.P. (2012). Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012 Jun;33(3):378-455. doi: 10.1210/er.2011-1050.

Vandenberg, L., MV, M., & PH, W. (2007). Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology, 148, 116–127.

Vandenberg, L. N., Chahoud, I., Heindel, J. J., Padmanabhan, V., Paumgartten, F. J. R., & Schoenfelder, G. (2010). Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Persp, 118(8), 1055–1070. 

Vandenberg, L. N., Chahoud, I., Padmanabhan, V., Paumgartten, F. J. R., & Schoenfelder, G. (2010). Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Persp, 118(8), 1051–1054. 

Vandenberg, L., PR, W., & Schaeberle. (2006). The mammary gland response to estradiol: Monotonic at the cellular level, non-monotonic at the tissue level of organization. J Steroid Biochem Molec Biol, 101, 263–274.

Vandenberg, LN, Wadia, P., Schaeberle, C., Rubin, B., Sonnenschein, C., & Soto, A. (2006). The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue level of organization? J Steroid Biochem Molec Biol, 101, 263–274.

Vandenberg, LN., Maffini, M., Schaeberle, C., Ucci, A., Sonnenschein, C., Rubin, B., & Soto, A. (2008). Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD01 mice. Reprod Toxicol, 26, 210–219.

Venkatesan, A. K., Pycke, B. F. G., Barber, L. B., Lee, K. E., & Halden, R. U. (2012). Occurrence of triclosan, triclocarban, and its lesser chlorinated congeners in Minnesota freshwater sediments collected near wastewater treatment plants. J Hazard Mater, 229-230, 29–35.

Verkooijen, H., Bouchardy, C., Vinh-Hung, V., Rapiti, E., & Hartman, M. (2009). The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence. Maturitas, 64, 80–85.

Verner, M.-A., Bachelet, D., McDougall, R., Charbonneau, M., Guénel, P., & Haddad, S. (2011). A case study addressing the reliability of polychlorinated biphenyl levels measured at the time of breast cancer diagnosis in representing early-life exposure. Cancer Eppidemiol, Biomar Prev, 20(2), 281–286.

Veronesi, U., Luini, A., Del Vecchio, M., Greco, M., Galimberti, V., Merson, M., … Salvadori, B. (1993). Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. New England J Med, 328, 1587–1591.

Verschaeve, L., Koppen, G., & Van_Gorp, U. (2007). Seasonal variations in spontaneous levels of DNA damage; implication in the risk assessment of environmental chemicals. J Appl Toxicol, 27, 612–620.

Vessey, M., & Painter, R. (2006). Oral contraceptive use and cancer: Findings in a large cohort study. Br J Cancer, 95, 385–389.

Villanueva, C., Durand, G., Coutté, M., Chevrier, C., & Cordier, S. (2005). Atrazine in municipal drinking water and risk of low birth weight, preterm delivery, and small-for-gestational-age status. Occup Environ Med, 62, 400–405.

Villeneuve, S., Cyr, D., Lynge, E., Orsi, L., Sabroe, S., Merletti, F., … Guénel, P. (2010). Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: A case-control study in Europe. Occup Environ Med 67(12), 837–844.

Villeneuve, Sara, Cyr, D., Lynge, E., Orsi, L., Sabroe, S., Merletti, F., … Guénel, P. (2010). Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occupational and environmental medicine, 67(12), 837–844. 

Vineis, P., Khan, A., Valaanderen, J., & Vermeulen, R. (2009). The impact of new research technologies on our understanding of environmental causes of disease: The concept of clinical vulnerability. Environ Health, 8, 54–64.

Vineis, P., & Perera, F. (2000). DNA adducts as markers of exposure to carcinogens and risk of cancer. International Journal of Cancer, 88(3), 325–328.

Völkel, W., Colnot, T., Csanády, G. A., Filser, J. G., & Dekant, W. (2002). Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Cheml Res  Toxicol, 15(10), 1281–1287.

Völkel, W., Kiranoglu, M., & Fromme, H. (2008). Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol Lett, 179(3), 155–162.

Vom Saal, F., Akingbemi, B., Belcher, S., Birnbaum, L., Crain, D., Eriksen, M., … Zoeller, R. (2007). Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol, 24, 131–138.

Vom Saal, F., Akingbemi, B., Belcher, S., Crain, D., Crews, D., Guidice, L., … Zoeller, R. (2010). Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci, 115, 612–613.

Vom Saal, F., & Hughes, C. (2005). An extensive literature concerning low-dose effects of bisphenol A show the need for a new risk assessment. Envir Health Persp, 113, 926–933.

Vorderstrasse, B., Fenton, S., Bohn, A., Cundiff, J., & Lawrence, B. (2004). A novel effect of dioxin: Exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci, 78, 248–257.


Wadia, P., Vandenberg, L., Schaeberle, C., Rubin, B., Sonnenschein, C., & Soto, A. (2007). Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse species. Environ Health Persp, 115, 80–86.

Wahner-Roedler, D., & Petersen, I. (2004). Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma. Drugs Today, 40, 865–79.

Walrath, J., Li, F., Hoar, S., Mead, M., & Fraumeni Jr., J. (1985). Causes of death among female chemists. Am J Public Health, 15, 883–885.

Wang, F., Kuo, M., Shun, C., Ma, Y., Wang, J., & Ueng, T. (2002). Chronic toxicity of a mixture of chlorinated alkanes and alkenes in ICR mice. J Toxicol Environ Health, 65, 279–291.

Wang, Y.-Y., Lehuédé, C., Laurent, V., Dirat, B., Dauvillier, S., Bochet, L., … Muller, C. (2012). Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer. Cancer Lett. 

Wania, F., Mackay, D., (1993). Global fractionation and cold condensation of low volatility organochlorine compounds in polar regions. Ambio 22, 10–18.

Warnberg, F., Yuen, J., & Holmberg, L. (2000). Risk of subsequent invasive cancer after breast cancer in situ. Lancet, 355, 724–725.

Warner, M., Eskanazi, B., Mocarelli, P., Gerthoux, P., Samuels, S., Needham, L., … Brambilla, P. (2002). Serum dioxin concentrations and breast cancer risk in the Seveso Women’s Health Study. Environ Health Persp, 110, 625–628.

Warner, M., Mocarelli, P., Samuels, S., Needham, L., Brambilla, P., & Eskenazi, B. (2011). Dioxin exposure and cancer risk in the Seveso Women’s Health Study. Environ Health Persp, 119(12), 1700–1705. 

Warri, A., Saarinen, N., Makela, S., & Hilakivi-Clarke, L. (2008). The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer, 98, 1485–1493.

Watson, C., Bulayeva, N., Wozniak, A., & Finnerty, C. (2005). Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens. Steroids, 70, 364–371.

Weber, R., Watson, A., Forter, M., & Oliaei, F. (2011). Persistent organic pollutants and landfills - A review of past experiences and future challenges. Waste Manage Res, 29(1), 107–121.

Wei, J., Lin, Y., Li, Y., Ying, C., Chen, J., Song, L., … Xu, S. (2011). Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology, 152(8), 3049–3061. 

Weiderpass, E., Pukkala, E., Kauppinen, T., Mutanen, P., Paakkulainen, H., Vasama-Neuvonen, K., … Partanen, T. (1999). Breast cancer and occupational exposures in women in Finland. Am J Ind Med, 36, 48–53.

Weise, E. (2004). Growth hormones in veal spark debate. USA Today, April, 1.

Weiss, J., Moysich, K., & Swede, H. (2005). Epidemiology of male breast cancer. Cancer Epidemiol Biomar Prev, 14, 20–26.

Welshons, W., Nagel, S., & Vom Saal, F. (2006). Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology, 147, 56–69.

Weng, Y.-I., Hsu, P.-Y., Liyanarachchi, S., Liu, J., Deatherage, D. E., Huang, Y.-W., … Huang, T. H.-M. (2010). Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol, 248(2), 111–121. 

Wennborg, H., Yuen, J., Axelsson, G., Ahlbom, G., Gustavsson, P., & Sasco, A. (1999). Mortality and cancer incidence in biomedical laboratory personnel in Sweden. Am J Ind Med, 35, 382–389.

Weschler, C. (2009). Changes in indoor pollutants since the 1950s. Atmospheric Environ, 43, 153–169.

Westerhoff, P., Yoon, Y., Snyder, S., & Wert, E. (2005). Fate of endocrine disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol, 39, 6649–6663.

Wetherill, Y. B., Akingbemi, B. T., Kanno, J., McLachlan, J. A., Nadal, A., Sonnenschein, C., … Belcher, S. M. (2007). In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol, 24(2), 178–198.

White, S. S., Calafat, A. M., Kuklenyik, Z., Villanueva, L., Zehr, R. D., Helfant, L., … Fenton, S. E. (2007). Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci: an official journal of the Society of Toxicology, 96(1), 133–144. 

White, S. S., Kato, K., Jia, L. T., Basden, B. J., Calafat, A. M., Hines, E. P., … Fenton, S. E. (2009). Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod Toxicol (), 27(3-4), 289–298. 

WHO, W. H. O. (1996). Levels of PCBs, PCDDs, and PCDFs in human milk. WHO European.

Wigle, D., Arbuckle, T., Turner, M., Berube, A., Yang, Q., Liu, S., & Krewski, D. (2008). Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health, 11, 373–517.

Wild, C. P. (2005). Complementing the genome with an “exposome”: The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomar Prev, 14(8), 1847–1850.

Windham, G., Pinney, S., Sjodin, A., Lum, R., Jones, R., Needham, L., … Kushi, L. (2010). Body burdens of brominated flame retardants and other persistent organo-halogenated compounds and their descriptors in US girls. Environ Res, 110(3), 251–257. 

Wittassek, M., Angerer, J., Kolossa-Gehring, M., Schafer, S., Klockenbusch, W., Dobler, L., … Wiesmuller, G. (2009). Fetal exposure to phthalates: a pilot study. Int J Hyg Environ Health, 212, 492–498.

Wolff, M. (1983). Occupationally derived chemicals in breast milk. Am J Ind Med, 4, 259–281.

Wolff, M., Teitelbaum, S., Pinney, S., Windham, G., Liao, L., Biro, F., … Calafat, A. (2010). Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols, and pubertal stages in girls. Environ Health Persp, 118, 1039–1046.

Wolff, M., Teitelbaum, S., Windham, G., Pinney, S., Britton, J., Chelimo, C., … Calafat, A. (2007). Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Persp (pp. 116–121).

Wolstenholme, J. T., Rissman, E. F., & Connelly, J. J. (2011). The role of Bisphenol A in shaping the brain, epigenome and behavior. Hormones and Behavior, 59(3), 296–305.

Woo, H. D., Park, K. S., Ro, J., & Kim, J. (2012). Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status. Nutrition and cancer, 64(2), 198–205.

Wood, C. E., Clarkson, T. B., Chen, H., Veenstra, T. D., Xu, X., Scott, L., & Cline, J. M. (2008). Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis. Menopause 15(5), 890–898. 

Woodruff, T. J., Zota, A. R., & Schwartz, J. M. (2011). Environmental chemicals in pregnant women in the united states: NHANES 2003- 2004. Environ Health Persp, 119(6), 878–885.

Woodruff, T., Parker, J., Kyle, A., & Schoendorf, K. (2003). Disparities in exposure to air pollution during pregnancy. Environ Health Persp, 111, 942–946.

Woolcott, C., Aronson, K., Hanna, W., SenGupta, S., McCready, D., Sterns, E., & Miller, A. (2001). Organochlorines and breast cancer risk by receptor status, tumor size and grade.. Cancer Causes Control, 12, 395–404.

World, W. H. O. (1996). Health Organization Levels of PCBs, PCDDs, and PCDFs in human milk. WHO European.

Wozniak, A., Bulayeva, N., & Watson, C. (2005). Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2  fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Persp, 113, 431–9.

Wright, E. (2004). Radiation-induced genomic instability: Manifestations and mechanisms. Int J Low Radiat, 1, 231–241.

Wróbel, A., & Gregoraszczuk, E.L. (2013). Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl-And propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells. Pharmacol Reports 65, 484–493.

Wu, A., Yu, M., Tseng, C., & Pike, M. (2008). Epidemiology of soy exposures and breast cancer risk. Br J Cancer, 98, 9–14.

Wu, H., Chou, S., Chen, D., & Kuo, H. (2006). Differentiation of serum levels of trace elements in normal and malignant breast patients. Biol Trace Elem Res, 113, 9–18.


Xian, C. (1995). Degradation of IGF-1 in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. J Endocrinol.

Xie, L., Thrippleton, K., Irwin, M., Siemering, G., Mekebri, A., Crane, D., … Schlenk, D. (2005). Evaluation of estrogenic activities of aquatic herbicides and surfactants using a rainbow trout vitellogenin assay. Toxicol Sci, 87, 91–398.

Xu, J., Wu, L., Chen, W., Jiang, P., & Chang, A. (2009). Pharmaceuticals and personal care products (PPCPs), and endocrine disrupting compounds (EDCs) in runoff from a potato field irrigated with treated wastewater in southern California. J Health Sci, 55, 306–310.

Xu, P., Ye, W., Jen, R., Lin, S., Kuo, C., & Lin, Y. (2009). Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol. Anticancer Res, 29, 4621–4628.

Xu, Pingping, Ye, W., Li, H., Lin, S.-H., Kuo, C.-T., Feng, E., & Lin, Y. C. (2010). Zeranol enhances leptin-induced proliferation in primary cultured human breast cancer epithelial cells. Mol Med Rep, 3(5), 795–800. 

Xu, Pingping, Ye, W., Zhong, S., Li, H., Feng, E., Lin, S.-H., … Lin, Y. C. (2010). Leptin and zeranol up-regulate cyclin D1 expression in primary cultured normal human breast pre-adipocytes. Mol Med Rep, 3(6), 983–990. 

Xue, F., Willett, W. C., Rosner, B. A., Hankinson, S. E., & Michels, K. B. (2011). Cigarette smoking and the incidence of breast cancer. Arch Inter Med, 171(2), 125–133. 


Yaffe, M. J., & Mainprize, J. G. (2011). Risk of radiation-induced breast cancer from mammographic screening. Radiology, 258(1), 98–105. 

Yang, Y. J., Hong, Y.-C., Oh, S.-Y., Park, M.-S., Kim, H., Leem, J.-H., & Ha, E.-H. (2009). Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environ Res, 109(6), 797–801. 

Yao, S., Zirpoli, G., Bovbjerg, D. H., Jandorf, L., Hong, C. C., Zhao, H., … Ambrosone, C. B. (2012). Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: A case-control study. Breast Cancer Res, 14(2).

Ye, W., Xu, P., Threlfall, W., Jen, R., Li, H., Lin, S., … Lin, Y. (2009). Zeranol enhances the proliferation of preadipocytes in beef heifers. Anticancer Res, 29, 5045–5052.

Ye, Weiping, Xu, P., Jen, R., Feng, E., Zhong, S., Li, H., … Lin, Y. C. (2011). Zeranol Down-Regulates p53 Expression in Primary Cultured Human Breast Cancer Epithelial Cells through Epigenetic Modification. Int J Molec Sci, 12(3), 1519–1532. 

Ye, Weiping, Xu, P., Zhong, S., Jen, R., Threlfall, W. R., Frasure, C. V., … Lin, Y. C. (2011a). In vitro transformation of MCF-10A cells by sera harvested from heifers two months post-Zeranol implantation. Int J Oncol, 38(4), 985–992. 

Ye, Weiping, Xu, P., Zhong, S., Jen, R., Threlfall, W. R., Frasure, C. V., … Lin, Y. C. (2011b). In vitro transformation of MCF-10A cells by sera harvested from heifers two months post-Zeranol implantation. Int J Oncol,, 38(4), 985–992. 

Ye, X., Kuklenyik, Z., Needham, L., & Calafat, A. (2006). Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatog, 831, 110–115.

Ye, X., Pierik, F., Angerer, J., Meltzer, H., Jaddoe, V., Tiemeier, H., … Longnecker, M. (2009). Levels of metabolites of organophosphate pesticides, phthalates, and bisphenol A in pooled urine specimens from pregnant women participating in the Norwegian mother and child cohort study. MoBa). Int J Hyg Environ Health, 212, 481–491.

Ying, M., Agrawal, A., & Cheung, K. (2005). The “other half” of breast cancer: a review of male breast cancer. J Men’s Health Gender, 2, 406–414.

Yoshioka, H., Hiromori, Y., Aoki, A., Kimura, T., Fujii-Kuriyama, Y., Nagase, H., & Nakanishi, T. (2012). Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells. Toxicol Lett, 211(3), 257–265. 

Yu, C., & Chu, K. (2009). Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee. Chemosphere, 75, 1281–1286.

Yu, L., & Zhan, P. (2009). Molecular mechanisms underlying proliferation and apoptosis in breast cancer MCF-7 cells induced by pentabrominated diphenyl ethers. Toxicol Environ Chem, 91, 665–670.

Yuri, T., Nikaido, Y., Shimano, N., Uehara, N., Shikata, N., & Tsubura, A. (2004). Effects of prepubertal zeranol exposure on estrogen target organs and N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats. In Vivo, 18, 755–762.

Yuri, Takashi, Tsukamoto, R., Miki, K., Uehara, N., Matsuoka, Y., & Tsubura, A. (2006). Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep, 16(6), 1307–1312.


Zarbl, H. (2007). Toxicogenomic analyses of genetic susceptibility to mammary gland carcinogenesis, in rodents: Implications for human breast cancer. Breast Disease, 28, 87–105.

Zhang, C.-X., Ho, S. C., Fu, J.-H., Cheng, S.-Z., Chen, Y.-M., & Lin, F.-Y. (2011). Dairy products, calcium intake, and breast cancer risk: a case-control study in China. Nutr Cancer, 63(1), 12–20. 

Zhang, M., Yang, H., & Holman, C. (2009). Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status. Breast Cancer Res Treat, 118, 553–563.

Zhang, Y., Wise, J. P., Holford, T. R., Xie, H., Boyle, P., Zahm, S. H., … Zheng, T. (2004). Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol, 160(12), 1177–1183.

Zhao, Y., Pan, J.-H., & Zhang, L.-L. (2012). Soy foods intake in adolescence and the risk of breast cancer: A systematic review. Chin J Evid Based Med, 12(5), 550–556.

Zheng, T., Holford, T., Mayne, S., Ward, B., Carter, D., Owens, P., … Tessari, J. (1999). DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol, 150, 453–458.

Zheng, T., Holford, T., Taylor Mayne, S., Luo, J., Hansen Owens, P., Hoar Zahm, S., … Boyle, P. (2002). A case-control study of occupation and breast cancer risk in Connecticut., J Cancer Epidemiol Prev, 7, 3–11.

Zhu, Y., Stevens, R., Leaderer, D., Hoffman, A., Holford, T., Zhang, Y., … Zheng, T. (2008). Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer. Breast Cancer Res Treat, 107, 421–425.

Zhu, Yong, Stevens, R. G., Hoffman, A. E., Tjonneland, A., Vogel, U. B., Zheng, T., & Hansen, J. (2011). Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronoiol Int 28(10), 852–861. 

Ziegler, R. (2000). Phytoestrogens and breast cancer. Am J Clin Nutr, 79, 183–184.

Ziegler, R., Hoover, R., Pike, M., Hildesheim, A., Nomura, A., West, D., … Hyer, M. (1993). Migration patterns and breast cancer risk in Asian American women. J Nat Cancer Inst, 85, 1819–27.

Zimmerman, L., Lima, R., Pietrobon, R., & Marcozzi, D. (2008). The effects of seasonal variation on hazardous chemical releases. J Hazard Mater, 151, 232–238.

Zorrilla, L. M., Gibson, E. K., Jeffay, S. C., Crofton, K. M., Setzer, W. R., Cooper, R. L., & Stoker, T. E. (2009). The effects of triclosan on puberty and thyroid hormones in male wistar rats. Toxicol Sci, 107(1), 56–64.

Zota, A. R., Rudel, R. A., Morello-Frosch, R. A., & Brody, J. G. (2008). Elevated house dust and serum concentrations of PBDEs in California: Unintended consequences of furniture flammability standards? Environ Science Technol, 42(21), 8158–8164.